PortfoliosLab logoPortfoliosLab logo
PFE vs. UNH
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

PFE vs. UNH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Pfizer Inc. (PFE) and UnitedHealth Group Incorporated (UNH). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

PFE vs. UNH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PFE
Pfizer Inc.
14.66%0.65%-2.22%-41.26%-10.41%66.70%3.07%-6.91%24.82%15.90%
UNH
UnitedHealth Group Incorporated
-17.39%-33.14%-2.41%0.80%6.94%45.20%21.25%20.00%14.52%39.83%

Fundamentals

Market Cap

PFE:

$159.66B

UNH:

$246.24B

EPS

PFE:

$1.36

UNH:

$15.62

PE Ratio

PFE:

20.61

UNH:

17.32

PS Ratio

PFE:

2.56

UNH:

0.55

PB Ratio

PFE:

1.72

UNH:

2.46

Total Revenue (TTM)

PFE:

$62.58B

UNH:

$447.57B

Gross Profit (TTM)

PFE:

$44.01B

UNH:

$82.92B

EBITDA (TTM)

PFE:

$15.10B

UNH:

$23.19B

Returns By Period

In the year-to-date period, PFE achieves a 14.66% return, which is significantly higher than UNH's -17.39% return. Over the past 10 years, PFE has underperformed UNH with an annualized return of 4.32%, while UNH has yielded a comparatively higher 9.39% annualized return.


PFE

1D
1.12%
1M
1.56%
YTD
14.66%
6M
14.02%
1Y
18.86%
3Y*
-6.22%
5Y*
-0.14%
10Y*
4.32%

UNH

1D
3.36%
1M
-7.02%
YTD
-17.39%
6M
-20.50%
1Y
-46.88%
3Y*
-15.31%
5Y*
-4.29%
10Y*
9.39%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PFE vs. UNH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PFE
PFE Risk / Return Rank: 6565
Overall Rank
PFE Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6161
Sortino Ratio Rank
PFE Omega Ratio Rank: 5959
Omega Ratio Rank
PFE Calmar Ratio Rank: 6969
Calmar Ratio Rank
PFE Martin Ratio Rank: 6969
Martin Ratio Rank

UNH
UNH Risk / Return Rank: 1212
Overall Rank
UNH Sharpe Ratio Rank: 66
Sharpe Ratio Rank
UNH Sortino Ratio Rank: 1010
Sortino Ratio Rank
UNH Omega Ratio Rank: 66
Omega Ratio Rank
UNH Calmar Ratio Rank: 1515
Calmar Ratio Rank
UNH Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PFE vs. UNH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Pfizer Inc. (PFE) and UnitedHealth Group Incorporated (UNH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PFEUNHDifference

Sharpe ratio

Return per unit of total volatility

0.71

-0.92

+1.63

Sortino ratio

Return per unit of downside risk

1.17

-1.15

+2.32

Omega ratio

Gain probability vs. loss probability

1.15

0.81

+0.33

Calmar ratio

Return relative to maximum drawdown

1.32

-0.77

+2.08

Martin ratio

Return relative to average drawdown

3.18

-1.02

+4.19

PFE vs. UNH - Sharpe Ratio Comparison

The current PFE Sharpe Ratio is 0.71, which is higher than the UNH Sharpe Ratio of -0.92. The chart below compares the historical Sharpe Ratios of PFE and UNH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


PFEUNHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.71

-0.92

+1.63

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

-0.14

+0.13

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

0.32

-0.13

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

0.60

-0.34

Correlation

The correlation between PFE and UNH is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

PFE vs. UNH - Dividend Comparison

PFE's dividend yield for the trailing twelve months is around 6.13%, more than UNH's 3.27% yield.


TTM20252024202320222021202020192018201720162015
PFE
Pfizer Inc.
6.13%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%
UNH
UnitedHealth Group Incorporated
3.27%2.64%1.62%1.38%1.21%1.12%1.38%1.41%1.38%1.30%1.48%1.59%

Drawdowns

PFE vs. UNH - Drawdown Comparison

The maximum PFE drawdown since its inception was -58.96%, smaller than the maximum UNH drawdown of -74.37%. Use the drawdown chart below to compare losses from any high point for PFE and UNH.


Loading graphics...

Drawdown Indicators


PFEUNHDifference

Max Drawdown

Largest peak-to-trough decline

-58.96%

-74.37%

+15.41%

Max Drawdown (1Y)

Largest decline over 1 year

-12.59%

-60.06%

+47.47%

Max Drawdown (5Y)

Largest decline over 5 years

-58.96%

-61.39%

+2.43%

Max Drawdown (10Y)

Largest decline over 10 years

-58.96%

-61.39%

+2.43%

Current Drawdown

Current decline from peak

-42.75%

-55.14%

+12.39%

Average Drawdown

Average peak-to-trough decline

-17.33%

-14.63%

-2.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.13%

45.40%

-39.27%

Volatility

PFE vs. UNH - Volatility Comparison

The current volatility for Pfizer Inc. (PFE) is 6.75%, while UnitedHealth Group Incorporated (UNH) has a volatility of 7.72%. This indicates that PFE experiences smaller price fluctuations and is considered to be less risky than UNH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


PFEUNHDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.75%

7.72%

-0.97%

Volatility (6M)

Calculated over the trailing 6-month period

18.50%

29.34%

-10.84%

Volatility (1Y)

Calculated over the trailing 1-year period

26.73%

51.10%

-24.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.46%

31.26%

-5.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.90%

29.84%

-5.94%

Financials

PFE vs. UNH - Financials Comparison

This section allows you to compare key financial metrics between Pfizer Inc. and UnitedHealth Group Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B120.00B20212022202320242025
17.56B
113.22B
(PFE) Total Revenue
(UNH) Total Revenue
Values in USD except per share items

PFE vs. UNH - Profitability Comparison

The chart below illustrates the profitability comparison between Pfizer Inc. and UnitedHealth Group Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%30.0%40.0%50.0%60.0%70.0%20212022202320242025
70.0%
16.3%
Portfolio components
PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.

UNH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a gross profit of 18.49B and revenue of 113.22B. Therefore, the gross margin over that period was 16.3%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.

UNH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported an operating income of 380.00M and revenue of 113.22B, resulting in an operating margin of 0.3%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.

UNH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, UnitedHealth Group Incorporated reported a net income of 2.18B and revenue of 113.22B, resulting in a net margin of 1.9%.